CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease

CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease

Abstract Since its discovery in 2012, CRISPR Cas9 has been tried as a direct treatment approach to correct the causative gene mutation and establish animal models in neurodegenerative disorders. Since no strategy developed until now could completely cure Parkinson's disease (PD), neuroscientist...

Full description

Bibliographic Details
Main Authors: Poojitha Pinjala, Kamatham Pushpa Tryphena, Renuka Prasad, Dharmendra Kumar Khatri, Woong Sun, Shashi Bala Singh, Dalapathi Gugulothu, Saurabh Srivastava, Lalitkumar Vora
Format: Article
Language:English
Published: American Association for the Advancement of Science (AAAS) 2023-05-01
Series:Biomaterials Research
Subjects:
Neurodegenerative disorder
α-synuclein
Gene editing
Human pluripotent stem cells
Embryonic stem cells
Disease model
Online Access:https://doi.org/10.1186/s40824-023-00381-y

Internet

https://doi.org/10.1186/s40824-023-00381-y

Similar Items